Lung cancer trial | Daiichi Sankyo Europe GmbH

Welcome to this lung cancer trial website

  • Imprintǀ
  • Legal Disclaimerǀ
  • Contactǀ
  • Sitemap

Print Page

  • Home
  • About This Trial
  • About Clinical Trials
  • Clinical trials FAQ
  • About Lung Cancer
  • Resources & Links
  • About Daiichi Sankyo

Sitemap

  • Home
  • About This Trial
  • About Clinical Trials
    • Introduction to clinical trials
    • Details about clinical trials
    • The different phases of clinical trials
    • Different types of clinical research
    • How to participate in clinical trials
    • The informed consent
    • What you should know about benefits and risks
    • Questions to ask your doctor
  • Clinical trials FAQ
  • About Lung Cancer
    • Introduction to lung cancer
    • What is lung cancer?
    • Who is at risk?
    • Common symptoms of lung cancer
    • How is lung cancer diagnosed?
    • Stages of lung cancer
    • Treatment of lung cancer
    • Prevention of lung cancer
  • Resources & Links
  • About Daiichi Sankyo

A lung cancer trial

This trial is a Phase III clinical trial examining the treatment of non-squamous, non-small cell lung cancer (NSCLC) with a new investigational drug. It is co-sponsored by Daiichi Sankyo and ArQule and has the clinicaltrials.gov identifier NCT01244191.


Learn about this lung cancer trial

Find more details at clinicaltrials.gov

Clinical trials FAQ

  • What is a protocol?

    A protocol outlines in detail all aspects of the clinical study—including who can participate, what treatments are to be [...]

  • How is the wellbeing of participants protected?

    The clinical trial protocol must be approved by regulatory authorities and independent committees charged with safeguarding [...]

  • What is informed consent?

    Informed consent refers to the process by which potential study participants are informed about the clinical trial through [...]

  • Who can participate in a clinical trial?

    The requirements for eligibility are specific to each clinical trial. Criteria are based on factors such as the type and [...]

  • Who sponsors clinical trials?

    Clinical trials are sponsored by a wide variety of medical institutions including pharmaceutical and biopharmaceutical [...]

  • How do I get started?

    After you or your doctor has identified a study that you may be eligible for, your doctor can refer you to a study center [...]


All Clinical Trials FAQ

Recommend this website

Do you find this website useful? Do you know someone who is thinking about participating in a clinical trial? Recommend this website.


Recommend website

Do you need more information?

Please contact us for more information about clinical trials.
Contact us via our contact form or send an email to oncology@daiichi-sankyo.eu.


Contact us

A lung cancer trial website

This website is designed to assist patients and other people seeking general information about clinical trials, as well as those interested in learning about this Phase III lung cancer trial. It explains key concepts about clinical research, the types of clinical trials, risks and benefits of participating in a clinical, and how to talk to your doctor. Information about lung cancer and this lung cancer trial is provided to support patients with lung cancer who are considering participating in a clinical trial. It is not intended to diagnose or treat lung cancer, or to substitute for the medical advice of your doctor. See your doctor to determine what treatment is best for you.

Navigation

  • Home
  • About This Trial
  • About Clinical Trials
  • Clinical trials FAQ
  • About Lung Cancer
  • Resources & Links
  • About Daiichi Sankyo

Copyright © Daiichi Sankyo Europe GmbH. All rights reserved.

  • Lung cancer trial